Skip to content

How Low Can You Go

How Low Can You Go: a Randomized Controlled Trial of Normal Versus Low Intraabdominal Pressure During Laparoscopic Uterosacral Suspension Surgery

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07786337
Enrollment
164
Registered
2026-08-26
Start date
2026-09-01
Completion date
2028-02-01
Last updated
2026-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse

Keywords

pelvic organ prolapse, laparoscopy, insufflation

Brief summary

This is a randomized controlled trial to determine if lower intraabdominal operating pressure reduces post-operative pain in patients scheduled to undergo laparoscopic uterosacral suspension surgery of the uterus or vaginal vault.

Detailed description

The primary objective of this research proposal is to answer the question: in patients scheduled to undergo laparoscopic uterosacral suspension surgery of the uterus or vaginal vault, does lower intraabdominal operating pressure reduce post-operative pain, measured using a standardized visual analogue scale? Secondary outcomes include frequency of opioid and non-opioid analgesic prescriptions at time of discharge, rescue opioid analgesics in the day-surgery recovery unit, rate of unanticipated admission to hospital. Surgical safety outcomes will also be assessed including surgeon perception of operative field visibility, rate of surgeon requests to increase intraabdominal pressure, rate of conversion to open surgery, incidence of surgical complications (up to 30d post-operatively). 3.0 METHODS & STATISTICAL ANALYSIS This study will be a double-blinded randomized controlled trial patients ≥18 years of age scheduled for laparoscopic uterosacral suspension surgery of either the uterus or vaginal vault at the Foothills Medical Centre, an academic tertiary hospital. Patients scheduled to receive concomitant prolapse, hysterectomy, or anti-incontinence surgeries will be included. Patients scheduled to receive concomitant non-urogynecologic surgery or those converted to an open, abdominal surgical approach will be excluded. For participants randomized to the lower IAP group, after entry into the abdominal-pelvic cavity, pneumoperitoneum pressure will be set and maintained at 10mmHg throughout the surgery. For those randomized to the normal IAP group, after entry into the abdominal-pelvic cavity, pneumoperitoneum pressure will be set and maintained at 15mmHg. Data collected - including but not limited to: 1. Preoperative data: a. Baseline demographics: age, BMI, past medical history 2. Intraoperative Data: 1. Duration of surgery, estimated blood loss, surgical complications 2. Incidence of surgeon request for either: an increase in Trendelenburg positioning or increase in intraabdominal pressure settings 3. Postoperative Data: 1. Visual analogue pain scores (0-100mm) at 3 and 24 hours postoperatively 2. Incidence of postoperative non-opioid and opioid prescriptions provided 3. Incidence of unplanned hospital admission The baseline characteristics of the primary cohort will be presented. Categorical data will be reported as counts and percentages and continuous data as means with standard deviations. Continuous variables will be analyzed using a Student t-test for normally distributed data and Wilcoxon's rank sum test for nonparametric data. Frequencies and percentages will be calculated for categorical variables and compared using the Chi-squared or Fisher's exact test as appropriate. Statistical significance will be defined as p\<0.05. Prior studies determined the minimum clinically significant difference in visual analogue pain scales scores to be 10mm, regardless of severity of pain. On the basis of this, a sample of 64 patients per group will be sought to achieve 80% power to detect an effect size of 0.5 (i.e. assuming a standard deviation of two points on the pain scale) using a two-group t-test with a two-sided significance level of 0.05. Accounting for a drop-out rate of 20%, a final sample size to 164 patients will be required.

Interventions

standard insufflation pressure of 15 mm Hg

PROCEDURELow insufflation

10 mm Hg of insufflation pressure

Sponsors

University of Calgary
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥18 years of age * planned laparoscopic uterosacral suspension surgery of the uterus or vaginal vault * patients with planned concomitant prolapse, hysterectomy, or anti-incontinence surgeries will be included

Exclusion criteria

* non-urogynecologic procedures, or conversion to open abdominal surgery will be excluded as additional or alternative sites of pain may contribute to possible confounding for the primary outcome of postoperative pain

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Pain Visual Analog Scale3 hours and 24 hours postopVisual analog scale minimum 0 maximum 10 0 means no pain 10 means worst possible pain

Secondary

MeasureTime frameDescription
Post-operative analgesia0 - 3 days postoperativetotal dose of morphine milligram equivalents MME used during first days after surgery.
Surgeon visibilityimmediately after surgerysurgeon rating of intraoperative visibility on a Likert scale of 0 - 10. 0 means no visibility. 10 = optimum visibility.

Contacts

CONTACTShunaha Kim-Fine, MD MS
skimfine@ucalgary.ca403-944-1438
CONTACTLouise Gofton
403-944-1438

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 27, 2026